A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)
Clinical trial NCT02924766 · COMPLETED
Trial details
- NCT number
- NCT02924766
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-03
- Primary completion
- 2019-07-18
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.